2010
DOI: 10.1016/j.colsurfb.2010.07.016
|View full text |Cite
|
Sign up to set email alerts
|

Coimmobilization of heparin/fibronectin mixture on titanium surfaces and their blood compatibility

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
21
0

Year Published

2012
2012
2016
2016

Publication Types

Select...
7
1

Relationship

3
5

Authors

Journals

citations
Cited by 34 publications
(22 citation statements)
references
References 43 publications
1
21
0
Order By: Relevance
“…However, although heparin is assembled to Ti surface, the heparin could restrain the adhesion and activation of platelets. The results are consistent with observations reported by others 13, 33. After incubation for 2 h, there were more aggregates and pseudopodia of platelets on Ti and Ti–OH surface, but the platelets on LBL surface remained mainly constant.…”
Section: Resultssupporting
confidence: 93%
“…However, although heparin is assembled to Ti surface, the heparin could restrain the adhesion and activation of platelets. The results are consistent with observations reported by others 13, 33. After incubation for 2 h, there were more aggregates and pseudopodia of platelets on Ti and Ti–OH surface, but the platelets on LBL surface remained mainly constant.…”
Section: Resultssupporting
confidence: 93%
“…Heparin and heparin‐mimicking polymers have been widely used to improve the anticoagulant ability of materials. Li et al immobilized a mixture of heparin and fibronectin onto titanium substrate via physisorption or covalent coimmobilization, the APTT value was prolonged from 45 to about 120 s . Wang et al covalently grafted heparin onto silk fibroin and then blended with chitosan to prepare dual‐functional composite membrane with anticoagulant and antibacterial properties, and the clotting times for the composite membrane surpassed the instrument limit set (APTT, 120 s; TT, 120 s) .…”
Section: Resultsmentioning
confidence: 99%
“…In addition, more efforts on heparin research have been made to develop the cross-linking multilayer, such as heparin/fibronectin (196,197), alginate/heparin (188), collagen/heparin (198), and dexamethasone-heparin systems (199), which benefit from the cooperative effects of heparin and the other molecules. Although heparin has been used clinically for treatment of thrombosis, it suffered from its short duration within compartments in vivo that require long-term anticoagulation.…”
Section: Heparin-bound Coatingsmentioning
confidence: 99%